1. Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10(5):295–7.
2. National Institute for Health and Care Excellence. Medical technologies guidance. London: NICE; 2021. Available at: https://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-medical-technologies-guidance. Accessed 14 May 2021.
3. Poole RL, Dale M, Morgan H, Ryczek E, Cohen B, Carolan-Rees G. Axonics sacral neuromodulation system for treating refractory overactive bladder (external assessment report). 2019. Available at: https://www.nice.org.uk/guidance/mtg50/documents/supporting-documentation-2. Accessed 21 Mar 2021.
4. National Institute for Health and Care Excellence. Axonics sacral neuromodulation system for treating refractory overactive bladder. London: NICE; Sep 2020. (Medical technologies guidance [MTG50]). Available at: https://www.nice.org.uk/guidance/mtg50. Accessed 21 Mar 2021.
5. McCrery R, Lane F, Benson K, et al. Treatment of urinary urgency incontinence using a rechargeable SNM system: 6-month results of the ARTISAN-SNM study. J Urol. 2020;203:185–92.